Especially the persistence of a TH2 subset, which displays an inflammatory memory phenotype in non-lesioned AD skin, was suggested to play a major role in the recurrence of AD conditions in patients treated with the monoclonal anti-IL-4Rα antibody dupilumab (66). Here, IL4R is linked to Alzheimer disease.